Back

Daprodustat in renal anaemia: changing the response to cellular hypoxia, but is it a game changer?

Cardiovascular Research

26 May 2022
Organised by: Logo
Read full article
ESC Journals

Contributors

Michael K Sullivan
Michael K Sullivan

Author

Patrick B Mark
Patrick B Mark

Author

You may be interested in
thumbnail
Congress Presentation
Daprodustat in patients with heart failure and renal anemia: multicenter, open-label, randomized controlled study
17 May 2025
thumbnail
Congress Presentation
Hepcidin and cardiovascular events in patients with chronic kidney disease undergoing dialysis: a post-hoc analysis of the ASCEND-D trial
1 September 2025
thumbnail
Congress Presentation
Experience of using sacubitril - valsartan in dialysis patients
29 June 2021
thumbnail
Congress Session
Does aldosterone synthase inhibition hold a key to transforming cardiorenal care?
19 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources